State Street Corp Aldeyra Therapeutics, Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 957,720 shares of ALDX stock, worth $5.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

957,720

Previous 939,569 1.93%

Holding current value

$5.27 Million

Previous $3.07 Million 3.19%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.25 - $4.72 $58,990 - $85,672	18,151 Added 1.93%	957,720 $3.17 Million
Q1 2024 May 15, 2024	BUY	$2.77 - $4.22 $112,351 - $171,163	40,560 Added 4.51%	939,569 $3.07 Million
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $3.19 Million - $13.1 Million	-2,166,958 Reduced 70.68%	899,009 $3.16 Million
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $147,257 - $196,664	24,101 Added 0.79%	3,065,967 $20.5 Million
Q2 2023 Aug 14, 2023	BUY	$7.11 - $11.89 $20.4 Million - $34.1 Million	2,868,585 Added 1655.45%	3,041,866 $25.5 Million
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $3,048 - $4,254	-600 Reduced 0.35%	173,281 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $1.71 Million - $3.41 Million	-703,916 Reduced 80.19%	173,881 $694,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $7.16 Million - $11.4 Million	-2,204,555 Reduced 71.52%	877,797 $3.9 Million
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $1.21 Million - $3.32 Million	-345,027 Reduced 10.07%	3,082,352 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $2.34 Million - $3.33 Million	294,240 Added 9.39%	3,427,379 $30.1 Million
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $7.41 Million - $10.5 Million	710,115 Added 29.31%	3,133,139 $35.5 Million
Q1 2021 May 17, 2021	BUY	$6.53 - $14.42 $15.7 Million - $34.6 Million	2,402,324 Added 11605.43%	2,423,024 $28.8 Million
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $10,096 - $13,008	1,600 Added 8.38%	20,700 $142,000
Q2 2020 Aug 14, 2020	SELL	$1.97 - $5.05 $756,300 - $1.94 Million	-383,909 Reduced 95.26%	19,100 $80,000
Q1 2020 May 11, 2020	BUY	$1.62 - $6.4 $652,874 - $2.58 Million	403,009 New	403,009 $995,000

Others Institutions Holding ALDX

# of Institutions

106

Shares Held

35.1M

Call Options Held

153K

Put Options Held

83.9K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $321M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Aldeyra Therapeutics, Inc. Transaction History